Skip to content
10-K

Annual Report

CG Oncology, Inc. CGON

0001193125-26-079498

← back to feed
Filed
Feb 27, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 25, 2026 84.44M sh
Shares Diluted FY 2025 · Dec 31, 2025 77.3M sh
Shares Diluted FY 2025 · Dec 31, 2024 62.5M sh
Shares Diluted FY 2025 · Dec 31, 2023 4.33M sh
Capex FY 2025 · Dec 31, 2025 $134K
Capex FY 2025 · Dec 31, 2024 $234K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$132.35M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$78.71M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$45.68M
Long Term Debt FY 2025 · Dec 31, 2025 $3M
Long Term Debt FY 2025 · Dec 31, 2024 $0
Cash And Equivalents FY 2025 · Dec 31, 2025 $32.49M
Cash And Equivalents FY 2025 · Dec 31, 2024 $257.07M
Stockholders Equity FY 2025 · Dec 31, 2025 $752.6M
Stockholders Equity FY 2025 · Dec 31, 2024 $733.38M
Stockholders Equity FY 2025 · Dec 31, 2023 −$123.1M
Stockholders Equity FY 2025 · Dec 31, 2022 −$77.69M
Current Liabilities FY 2025 · Dec 31, 2025 $30.84M
Current Liabilities FY 2025 · Dec 31, 2024 $21.37M
Total Liabilities FY 2025 · Dec 31, 2025 $38.99M
Total Liabilities FY 2025 · Dec 31, 2024 $21.42M
Current Assets FY 2025 · Dec 31, 2025 $759.48M
Current Assets FY 2025 · Dec 31, 2024 $754.21M
Total Assets FY 2025 · Dec 31, 2025 $791.59M
Total Assets FY 2025 · Dec 31, 2024 $754.8M
Eps Diluted FY 2025 · Dec 31, 2025 −$2.08
Eps Diluted FY 2025 · Dec 31, 2024 −$1.41
Eps Diluted FY 2025 · Dec 31, 2023 −$15.65
Eps Basic FY 2025 · Dec 31, 2025 −$2.08
Eps Basic FY 2025 · Dec 31, 2024 −$1.41
Eps Basic FY 2025 · Dec 31, 2023 −$15.65
Sga Expense FY 2025 · Dec 31, 2025 $73.53M
Sga Expense FY 2025 · Dec 31, 2024 $33.7M
Sga Expense FY 2025 · Dec 31, 2023 $9.9M
Rd Expense FY 2025 · Dec 31, 2025 $116.64M
Rd Expense FY 2025 · Dec 31, 2024 $82.1M
Rd Expense FY 2025 · Dec 31, 2023 $45.75M
Net Income FY 2025 · Dec 31, 2025 −$161M
Net Income FY 2025 · Dec 31, 2024 −$88.04M
Net Income FY 2025 · Dec 31, 2023 −$48.61M
Operating Income FY 2025 · Dec 31, 2025 −$190.77M
Operating Income FY 2025 · Dec 31, 2024 −$114.67M
Operating Income FY 2025 · Dec 31, 2023 −$55.45M
Revenue FY 2025 · Dec 31, 2025 $4.04M
Revenue FY 2025 · Dec 31, 2024 $1.14M
Revenue FY 2025 · Dec 31, 2023 $204K